Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Healthtrust
Accenture
Chinese Patent Office
US Department of Justice
Harvard Business School

Generated: March 23, 2019

DrugPatentWatch Database Preview

AMLEXANOX Drug Profile

« Back to Dashboard

Which patents cover Amlexanox, and what generic alternatives are available?

Amlexanox is a drug marketed by Uluru and is included in one NDA.

The generic ingredient in AMLEXANOX is amlexanox. Additional details are available on the amlexanox profile page.

Summary for AMLEXANOX
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 90
Clinical Trials: 3
Patent Applications: 789
DailyMed Link:AMLEXANOX at DailyMed
Drug patent expirations by year for AMLEXANOX
Synonyms for AMLEXANOX
2-amino-5-oxo-7-(propan-2-yl)-5H-chromeno[2,3-b]pyridine-3-carboxylic acid
2-amino-5-oxo-7-propan-2-yl-3-[1]benzopyrano[2,3-b]pyridinecarboxylic acid
2-amino-5-oxo-7-propan-2-ylchromeno[2,3-b]pyridine-3-carboxylic acid
2-Amino-7-(1-methylethyl)-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid
2-amino-7-(1-methylethyl)-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid
2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid
2-amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3b)pyridine-3-carboxylic acid
2-Amino-7-isopropyl-5-oxo-5H-[1]benzopyrano[2,3-b] pyridine-3-carboxylic acid
2-Amino-7-isopropyl-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid
2-Amino-7-isopropyl-5-oxo-5H-chromeno-[2,3-b]pyridine-3-carboxylic acid
2-Amino-7-isopropyl-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid
2-amino-7-isopropyl-5-oxo-chromeno[2,3-b]pyridine-3-carboxylic acid
2-Amino-7-isopropyl-5-oxochromeno[2,3-b]pyridine-3-carboxylic Acid
2-azanyl-5-oxidanylidene-7-propan-2-yl-chromeno[2,3-b]pyridine-3-carboxylic acid
302A578
4CH-008873
4wbo
5H-(1)Benzopyrano(2,3-b)pyridine-3-carboxylic acid, 2-amino-7-(1-methylethyl)-5-oxo-
68302-57-8
A836094
AA 673
AA-673
AB0013295
AB00639947_08
AB00639947-06
AC-1192
AC1L1D23
ACN-S001255
AJ-79212
AK-72823
AKOS015900498
Amlenanox
Amlexanox (JP17/USAN/INN)
Amlexanox [USAN:INN:BAN:JAN]
Amlexanox [USAN:INN:JAN]
Amlexanox, >=98% (HPLC)
Amlexanox, United States Pharmacopeia (USP) Reference Standard
Amlexanoxo
Amlexanoxo [Spanish]
Amlexanoxum
Amlexanoxum [Latin]
Amoxanox
AN-6555
ANW
ANW-44913
Aphthasol
Aphthasol (TN)
API0001459
Aptheal
Apthera
AX8016307
BC205443
BCP28222
BIDD:GT0709
BR-72823
BRL1C2459K
BRN 0556384
C-18659
C16H14N2O4
CA0192
CAS-68302-57-8
CC-24088
CCG-100953
CCRIS 2686
CHEBI:31205
CHEMBL1096
CHX 3673
CHX-3673
CPD000466352
CS-2949
CTK8B4400
D01828
DB01025
DS-1396
DSSTox_CID_2595
DSSTox_GSID_22595
DSSTox_RID_76651
DTXSID2022595
Elics
FT-0641176
GP9065
GTPL7113
H834
HMS2051F13
HMS2235M08
HMS3393F13
HMS3715B14
HY-B0713
I14-0660
J90008
KB-228144
KS-00000I13
L001037
LS-39875
M-8361
MFCD00864790
MLS000759466
MLS001424059
MLS006010129
MolPort-005-934-117
NC00203
NCGC00167472-01
NCGC00167472-02
NCGC00167472-03
OraDisc
OraDisc A
OraRinse
SAM001246669
SC-13770
SCHEMBL29642
SMR000466352
Solfa
Solfa (TN)
ST2409574
Tox21_112476
Tox21_112476_1
TR-022841
UNII-BRL1C2459K
ZINC928

US Patents and Regulatory Information for AMLEXANOX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Uluru AMLEXANOX amlexanox PATCH;TOPICAL 021727-001 Sep 29, 2004 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Chubb
Teva
Argus Health
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.